Search results for "030232 urology & nephrology"

showing 10 items of 360 documents

Tunnelled Haemodialysis Catheter Removal: An Underappreciated Problem, Not Always Simple and Safe

2020

Background: Optimal care of patients treated with a central tunneled catheter (CTC) as vascular access for hemodialysis requires a number of procedures. One of them is CTC removal, usually carried out using mostly the cut-down method (CDM) and the traction method (TM). The procedure seems to be simple and safe

Malemedicine.medical_specialtyCatheterization Central Venouscentral tunneled cathetersHealth Toxicology and Mutagenesismedicine.medical_treatment030232 urology & nephrologyVascular accesslcsh:Medicine030204 cardiovascular system & hematologyTraction MethodArticle03 medical and health sciences0302 clinical medicineCatheters IndwellingRenal DialysismedicineHumansIn patientTunneled catheterDevice Removalchronic kidneys diseaseAgedRetrospective StudiesAged 80 and overhemodialysisbusiness.industrylcsh:RPublic Health Environmental and Occupational Healthvascular accessMiddle AgedSurgeryTreatment OutcomeHaemodialysis catheterFemaleHemodialysisbusinessInternational Journal of Environmental Research and Public Health
researchProduct

Postoperative complications and 90-day mortality in radical cystectomy in high-risk patients: A monocentric retrospective observational study.

2018

Aim: Assessing the incidence of immediate postoperative complications and 90-day mortality in high-risk patients who have undergone radical cystectomy; evaluating the correlation between preoperative conditions and surgery outcomes. Materials and methods: This is a monocentric retrospective observational study in which data of 65 patients have been analyzed. High-risk criteria: (a) Age ≥75 years, (b) obesity, (c) age-adjusted Charlson Comorbidity Index ≥8, (d) anemic status, and (e) pT ≥3. More than 50% of patients had two or more “high-risk” indicators. Postoperative complications were assessed through Clavien–Dindo classification. Results: Average age of patients was 70.4 years, average a…

Malemedicine.medical_specialtyClavien-Dindo ClassificationTime Factorsmedicine.medical_treatment030232 urology & nephrologyCystectomyRisk AssessmentSettore MED/24 - UrologiaCystectomy03 medical and health sciences0302 clinical medicinePostoperative ComplicationsmedicineHumansRisk factorAgedRetrospective Studiesbusiness.industryMortality rateIncidence (epidemiology)Retrospective cohort studyGeneral MedicineOdds ratioMiddle AgedSurgeryUrinary Bladder Neoplasms030220 oncology & carcinogenesisRadical cystectomy bladder cancer Clavien–Dindo classification complications and mortalityFemalebusinessBody mass indexUrologia
researchProduct

Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral…

2020

Objectives: The aim of this multicenter study was to investigate the prognostic role of type 2 diabetes mellitus (T2DM) comorbidity in a large multi-institutional cohort of patients with primary T1HG/G3 non–muscle-invasive bladder cancer (NMIBC) treated with transurethral resection of the bladder (TURB). Materials and methods: A total of 1,172 patients with primary T1 HG/G3 who had NMIBC on re-TURB and who received adjuvant intravesical bacillus Calmette-Guérin therapy with maintenance were included. Endpoints were recurrence-free survival and progression-free survival. Results: A total of 231 (19.7%) of patients had T2DM prior to TURB. Five-year recurrence-free survival estimates were 12.5…

Malemedicine.medical_specialtyDiabetes mellituUrologymedicine.medical_treatment030232 urology & nephrologyUrologyCystectomyResection03 medical and health sciences0302 clinical medicineDiabetes mellitusHigh gradeAdjuvants ImmunologicUrethraRecurrenceDiabetes mellitusmedicineHumansIn patientNeoplasm InvasivenessAgedNeoplasm StagingRetrospective StudiesBladder cancerProgressionbusiness.industryHigh riskBladder cancerType 2 Diabetes MellitusMiddle Agedmedicine.diseasePrognosisComorbidityProgression-Free Survival3. Good healthBladder cancer; Diabetes mellitus; High grade; High risk; Progression; RecurrenceSettore MED/24OncologyDiabetes Mellitus Type 2Urinary Bladder NeoplasmsChemotherapy Adjuvant030220 oncology & carcinogenesisCohortBCG VaccineFemaleNeoplasm GradingbusinessAdjuvantUrologic oncology
researchProduct

Epidemiology of enuresis: a large number of children at risk of low regard

2020

Abstract Aim To describe the epidemiological aspects of nocturnal enuresis (NE). In this study we identify the prevalence and the familial conditions in a large, representative sample of children with monosymptomatic NE (MNE) and nonmonosyptomatic NE (NMNE). Material and methods In this descriptive-analytic study the Italian Society of Pediatrics (SIP) promoted a prevalence study of NE using a questionnaire involved 320 primary care Pediatricians from Northern, Central and Southern Italy, from January 2019 to July 2019, with a total of 130,000 children analyzed by questionnaire related to epidemiology and type of NE, familiarity, quality of sleep, eating and drinking habits, pharmacological…

Malemedicine.medical_specialtyFamily involvementEpidemiologyQuality of sleep030232 urology & nephrologyPrimary care03 medical and health sciences0302 clinical medicineRisk FactorsEnuresisSurveys and Questionnaires030225 pediatricsIntervention (counseling)EpidemiologyPrevalenceEnuresiHumansMedicineChildChildrenRetrospective Studiesbusiness.industryResearchlcsh:RJ1-570lcsh:PediatricsEnuresisSettore MED/38Drinking habitsItalyChild PreschoolFamily medicineFemaleSymptom Assessmentmedicine.symptombusinessNegative reactionNocturnal Enuresis
researchProduct

Effect on postoperative survival of the status of distal ureteral margin: The necessity to achieve negative margins at the time of radical cystectomy.

2015

Background: Despite several studies, the adequate management of positive distal ureter margins at the time of radical cystectomy (RC) remains controversial. Particularly, it is not clear whether the achievement of negative distal ureter margins at the intraoperative frozen sections (IFS) affects postoperative cancer-specific mortality (CSM). Methods: In all, 1,447 consecutive patients treated with RC at a single center between January 1987 and August 2014 were considered. Multivariable (MVA) logistic regression analyses were used to determine predictors of positive IFS. MVA Cox regression analyses were used to test the effect on CSM of intraoperative conversion to negative margins. Results:…

Malemedicine.medical_specialtyFrozen sectionUrologymedicine.medical_treatment030232 urology & nephrologySingle CenterCystectomySettore MED/24 - UrologiaUreteral marginCystectomy03 medical and health sciences0302 clinical medicineRetrospective StudiemedicineHumansPostoperative PeriodUreteral neoplasmSurvival analysisMarginAgedRetrospective StudiesBladder cancerbusiness.industryProportional hazards modelUreteral NeoplasmsCarcinoma in situBladder cancerOdds ratioUreteral NeoplasmMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryRadical cystectomyOncology030220 oncology & carcinogenesisFemaleSurvival AnalysibusinessHumanUrologic oncology
researchProduct

Fetuin-A is Associated to Serum Calcium and AHSG T256S Genotype but Not to Coronary Artery Calcification

2015

Vascular calcification has been recently associated to an increased cardiovascular risk and mortality. In few studies, Fetuin-A showed an association to coronary artery calcification (CAC), although the physiopathological mechanism underlying this association has not been fully established yet. Seventy-four patients with one or more cardiovascular risk factor and asymptomatic for coronary vasculopathy were included in the study. CAC was evaluated by Agatston score. Serum Fetuin-A levels were determined by ELISA. Molecular analysis of AHSG T256S gene variant (rs4918) was performed by PCR-RFLP. Serum Fetuin-A was correlated to serum calcium (r = 0,321; P = 0,018), but not to serum phosphorous…

Malemedicine.medical_specialtyGenotypealpha-2-HS-Glycoprotein030232 urology & nephrologychemistry.chemical_elementCoronary artery calcification030204 cardiovascular system & hematologyBiologyCalciumGastroenterologyAsymptomaticPolymorphism Single NucleotideCoronary artery diseaseBiochemistryCoronary artery disease03 medical and health sciences0302 clinical medicineGeneticInternal medicineGenotypeGeneticsmedicineHumansRisk factorAmplified Fragment Length Polymorphism AnalysisVascular CalcificationMolecular BiologyEcology Evolution Behavior and SystematicsAgedGeneral MedicineMiddle AgedSerum calciummedicine.diseaseFetuinCoronary VesselsFetuin-AEndocrinologySettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicachemistryAHSGCalciumFemalemedicine.symptomSettore MED/46 - Scienze Tecniche Di Medicina Di LaboratorioAgatston scoreSettore MED/36 - Diagnostica Per Immagini E Radioterapiaalpha-2-HS-glycoprotein
researchProduct

Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate

2021

Background: Although an increasing number of prostate cancer (PCa) patients received holmium laser enucleation of the prostate (HoLEP) previously for benign prostatic obstruction (BPO), there is still no evidence regarding the outcomes of radical prostatectomy (RP) in this setting. Objective: To assess functional and oncological results of RP in PCa patients who received HoLEP for BPO previously in a contemporary multi-institutional cohort. Design, setting, and participants: A total of 95 patients who underwent RP between 2011 and 2019 and had a history of HoLEP were identified in two institutions. Functional as well as oncological follow-up was prospectively assessed and retrospectively an…

Malemedicine.medical_specialtyHolmium laser enucleation of the prostate; Localized prostate cancer; Patient-reported outcomes; Radical prostatectomy; Urinary continenceUrologymedicine.medical_treatmentEnucleation030232 urology & nephrologyUrologyProstatic HyperplasiaUrinary incontinenceLasers Solid-State03 medical and health sciencesBladder outlet obstructionProstate cancerHolmium0302 clinical medicineErectile DysfunctionmedicineHumansRetrospective StudiesProstatectomyLocalized prostate cancerPatient-reported outcomesProstatectomybusiness.industryHazard ratioProstateUrinary continenceOdds ratiomedicine.diseaseRadical prostatectomyHolmium laser enucleation of the prostate030220 oncology & carcinogenesisPropensity score matchingmedicine.symptombusiness
researchProduct

Risk factors, complications and management of lymphocele formation after radical prostatectomy: A mini‐review

2019

Lymphocele formation is the most common adverse event of pelvic lymphadenectomy during radical prostatectomy for prostate cancer. Previous studies failed to favor one surgical technique over the other in terms of minimizing its rate. Data on risk factors for its development are still conflicting and warranting further research. In this mini-review, we aimed to scrutinize available evidence on these aspects and outline current achievements in lymphocele prevention approaches.

Malemedicine.medical_specialtyLymphoceleUrologymedicine.medical_treatment030232 urology & nephrologyPelvisMini review03 medical and health sciencesLymphoceleProstate cancer0302 clinical medicineRisk FactorsHumansMedicineAdverse effectPelvic lymphadenectomyProstatectomybusiness.industryProstatectomyGeneral surgeryProstatic Neoplasmsmedicine.disease030220 oncology & carcinogenesisLymph Node ExcisionbusinessInternational Journal of Urology
researchProduct

High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies

2017

Erectile dysfunction may be common among men with diabetes, but its prevalence is still debated. We aimed to assess the relative prevalence of erectile dysfunction in diabetes searching major databases from inception to November 2016 for studies reporting erectile dysfunction in men with Type 1 and Type 2 diabetes mellitus. We conducted a meta-analysis of the prevalence [and 95% confidence intervals (95% CIs)] of erectile dysfunction in diabetes compared with healthy controls, calculating the relative odds ratios (ORs) and 95% CIs. A random effect model was applied. From 3747 initial hits, 145 studies were included representing 88 577 men (age: 55.8 ± 7.9 years). The prevalence of erectile …

Malemedicine.medical_specialtyMEN 40Endocrinology Diabetes and Metabolism030232 urology & nephrology030209 endocrinology & metabolismReviewInternal Medicine; Endocrinology Diabetes and Metabolism; EndocrinologyOddsMELLITUS03 medical and health sciences0302 clinical medicineEndocrinologyErectile DysfunctionRisk FactorsDiabetes mellitusInternal medicinePrevalenceJournal ArticleInternal MedicineHumansEPIDEMIOLOGYMedicineHigh prevalencebusiness.industryType 2 Diabetes MellitusPublication biasmedicine.disease69 YEARS OLDConfidence intervalDiabetes and MetabolismErectile dysfunctionEndocrinologyDiabetes Mellitus Type 2BIASMeta-analysisHypertensionbusinessSEXUAL DYSFUNCTIONDiabetic Medicine
researchProduct

Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder

2017

Introduction: Lower urinary tract symptoms (LUTS) are frequent in motor neuron disease (MND) patients, but clinical factors related to them are unknown. We describe differences in LUTS among MND phenotypes and their relationship with other clinical characteristics, including prognosis. Methods: For this study, we collected clinical data of a previously published cohort of patients diagnosed with classical amyotrophic lateral sclerosis (cALS), progressive muscular atrophy (PMA) or primary lateral sclerosis (PLS) with and without LUTS. Familial history was recorded and the C9ORF72 expansion was analysed in the entire cohort Patients were followed-up for survival until August 2016. Results: Fi…

Malemedicine.medical_specialtyNeurogenic bladder030232 urology & nephrologyDiseaseMuscular Atrophy Spinal03 medical and health sciencesSex Factors0302 clinical medicineLower Urinary Tract SymptomsLower urinary tract symptomsC9orf72Primary lateral sclerosisInternal medicinemedicineHumansLower urinary tract symptomsMotor neuron diseaseMotor Neuron DiseaseUrinary Bladder NeurogenicFamily historyAmyotrophic lateral sclerosisAgedPrimary Lateral SclerosisC9orf72 Proteinbusiness.industryAmyotrophic Lateral SclerosisMiddle AgedProgressive muscular atrophyPrognosismedicine.diseaseAmyotrophic lateral sclerosisSurvival AnalysisSurgeryUrodynamicsCross-Sectional StudiesPhenotypeNeurologyProgressive muscular atrophyAmyotrophic lateral sclerosis Lower urinary tract symptoms Motor neuron disease Neurogenic bladder Primary lateral sclerosis Progressive muscular atrophy UrodynamicsMultivariate AnalysisCohortFemaleNeurology (clinical)business030217 neurology & neurosurgeryFollow-Up Studies
researchProduct